Glioblastoma: open trials in Australia

19 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT07524140
A First-in-Human Study of ZE94-0605 in Patients With Advanced Solid Tumors
Trial Treatment · Phase 1 · Eilean Therapeutics
SOCRU - Southern Oncology Clinical Research Unit, Bedford Park · St George Private Hospital, Kogarah
Registry updated 2026-11-09
NCT03970447
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Trial Treatment · Phase 2/3 · Global Coalition for Adaptive Research
Flinders Medical Centre, Bedford Park · Austin Health, Heidelberg · Royal Brisbane and Women's Hospital, Herston · Peter MacCallum Cancer Centre, Melbourne · Northern Sydney Cancer Centre/Royal North Shore Hospital, St Leonards · Calvary Mater Newcastle, Waratah
Registry updated 2026-11-02
NCT07908147
Biomarker-guided RAdiation-deferring Treatment in Younger GBM Patients - Pilot Study
Trial Treatment · Early phase 1 · Olivia Newton-John Cancer Research Institute
Austin Hospital, Heidelberg
Registry updated 2026-10-30
NCT06914128
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Trial Treatment · Phase 1/2 · Bayer
Chris O'Brien Lifehouse, Camperdown · Concord Repatriation General Hospital (CRGH) (Concord Hospital) - Concord Cancer Centre, Concord · Northern Hospital, Epping · Calvary Mater Hospital Newcastle - Oncology, Waratah
Registry updated 2026-10-28
NCT07739017
OLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed Glioblastoma
Trial Treatment · Phase 1 · Olivia Newton-John Cancer Research Institute
Princess Alexandra Hospital, Brisbane · Austin Health, Heidelberg · Royal Brisbane and Women's Hospital, Herston · The Alfred Hospital, Melbourne · Royal North Shore Hospital, Sydney · St Vincent's Hospital, Sydney
Registry updated 2026-10-28
NCT05303519
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Trial Treatment · Phase 3 · Nuvation Bio Inc.
St Vincents Hospital Sydney (Kinghorn), Darlinghurst · Royal Brisbane and Women's Hospital, Herston · The Alfred, Melbourne · Peter MacCallum Cancer Centre, Melbourne · Sir Charles Gairdner Hospital, Nedlands · Royal North Shore Hospital, Saint Leonards
Registry updated 2026-10-19
NCT04094610
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Perth Childrens Hospital, Nedlands · Randwick · Children's Health Queensland Hospital and Health Service, South Brisbane · Westmead
Registry updated 2026-09-25
NCT06816927
Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab
Trial Treatment · Phase 2 · Duke University
Peter MacCallum Cancer Centre, Parkville
Registry updated 2026-09-17
NCT06132438
Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma
Trial Treatment · Phase 1 · Charlotte Lemech
Ingham Institute of Applied Medical Research, Liverpool · Scientia Clinical Research, Randwick
Registry updated 2026-09-15
NCT05839379
Targeted Pediatric High-Grade Glioma Therapy
Research · Nationwide Children's Hospital
Royal Children's Hospital, Melbourne · Perth Children's Hospital, Perth · Sydney Children's Hospital, Randwick · Queensland Children's Hospital, South Brisbane
Registry updated 2026-09-08
NCT06161974
Study of Olutasidenib and Temozolomide in HGG
Trial Treatment · Phase 2 · Rigel Pharmaceuticals
Perth Children's Hospital, Perth · Sydney Children's Hospital, Randwick · Queensland Children's Hospital, South Brisbane
Registry updated 2026-09-01
NCT07052877
The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab
Research · Royal North Shore Hospital
Royal North Shore Hospital, Saint Leonards
Registry updated 2026-08-13
NCT07100730
Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma
Trial Treatment · Phase 3 · Telix Pharmaceuticals (Innovations) Pty Limited
Royal Adelaide Hospital, Adelaide · Gold Coast University Hospital, Gold Coast · Austin Health, Melbourne · Sir Charles Gairdner Hospital, Perth
Registry updated 2026-08-11
NCT07712770
Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma
Trial Treatment · Early phase 1 · Olivia Newton-John Cancer Research Institute
Austin Hospital, Melbourne
Registry updated 2026-07-17
NCT06333899
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Trial Treatment · Early phase 1 · Nationwide Children's Hospital
Perth Children's Hospital, Perth · Sydney Children's Hospital, Randwick · Queensland Children's Hospital, South Brisbane
Registry updated 2026-06-29
NCT05843253
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Trial Treatment · Phase 2 · Nationwide Children's Hospital
Royal Children's Hospital, Melbourne · Perth Children's Hospital, Perth · Sydney Children's Hospital, Randwick · Queensland Children's Hospital, South Brisbane
Registry updated 2026-05-29
NCT05500612
MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy
Research · University of Sydney
Royal North Shore Hospital, St Leonards · North Shore Private Hospital, St Leonards
Registry updated 2026-05-19
NCT06926075
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
Trial Treatment · Phase 1/2 · Filamon LTD
St George Private Hospital, Kogarah · South Western Sydney Local Health District, Liverpool · Southside Cancer Centre, Miranda
Registry updated 2026-03-17
NCT03175224
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Trial Treatment · Phase 2 · Apollomics Inc.
St Vincents Hospital Melbourne, Melbourne
Registry updated 2025-06-27

All Glioblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error